Inception Return
(10/16/2020)
|
2.96 %
|
|
YTD Return
|
8.06 %
|
|
NAVPS
(3/31/2025)
|
$10.92
|
|
Change
|
$0.10 / 0.95 %
|
|
|
Growth of $10,000
(As of February 28, 2025)
|
|
MER
|
2.66 %
|
|
Assets ($mil)
|
$54.20
|
|
Rank (1Yr)
|
174/190
|
|
Std Dev (3Yr)
|
-
|
|
Volatility Ranking (3Yr)
|
10/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Back Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund aims to provide long-term capital appreciation by investing primarily in long and short positions of equity securities of companies anywhere in the world. The Fund may use leverage through the use of short selling of up to 50% of its net asset value and by investing in derivatives. The Fund’s gross exposure shall not exceed the limits on the use of leverage or as otherwise permitted under applicable securities legislation and/or regulatory approval.
|
Fund Manager
Fidelity Investments Canada ULC
Portfolio Manager
Daniel Dupont, Fidelity Investments Canada ULC
Sub-Advisor
Fidelity Canada Investment Management
|
|
Asset Allocation
(As of December 31, 2024)
|
Sector Allocation
(As of December 31, 2024)
|
Geographic Allocation
(As of December 31, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| U.S. DOLLAR | Cash and Equivalents | Cash and Cash Equivalent | United States | 30.32% |
| Diageo PLC | International Equity | Consumer Goods | European Union | 4.70% |
| British American Tobacco PLC | International Equity | Consumer Goods | European Union | 4.62% |
| Imperial Brands PLC | International Equity | Consumer Goods | European Union | 4.57% |
| Remy Cointreau SA | International Equity | Consumer Goods | European Union | 4.07% |
| Metro Inc | Canadian Equity | Consumer Services | Canada | 3.81% |
| Bayer AG Cl N | International Equity | Healthcare | European Union | 3.61% |
| Nestle SA Cl N | International Equity | Consumer Goods | Other European | 3.50% |
| Pernod Ricard SA | International Equity | Consumer Goods | European Union | 3.43% |
| Pfizer Inc | US Equity | Healthcare | United States | 3.33% |
Performance Data
(As of February 28, 2025)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
9.95
|
10.61
|
-7.15
|
8.06
|
-1.08
|
-2.68
|
-
|
-
|
|
Benchmark
|
-0.40
|
-0.31
|
10.31
|
3.06
|
22.45
|
9.72
|
12.73
|
8.50
|
|
Quartile Ranking
|
1
|
1
|
4
|
1
|
4
|
4
|
-
|
-
|
|
Calendar Return (%)
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|
Fund
|
-17.47
|
-28.84
|
66.10
|
0.29
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Benchmark
|
21.65
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
|
Quartile Ranking
|
4
|
4
|
1
|
4
|
-
|
-
|
-
|
-
|
-
|
-
|